Baxter Oncology English
Products
Health Care Professionals
Patients
Quality Management
Contract Manufacturing
Manufacturing
Organization Contact Us Sitemap Baxter Oncology Homepage Baxter Homepage
 


Our Oncology business has been established worldwide with standard therapy products for cancer, such as ENDOXAN (cyclophosphamide), HOLOXAN (ifosfamide), and UROMITEXAN (mesna), for over 40 years. This product range has been steadily expanded to include, ONKOTRONE (mitoxantrone), BLEOMYCIN (Bleomycin) and others, some only available regionally.

The long-term objective is to help improve the treatment of cancer patients worldwide through the development, production, marketing, and sale of new, improved products in close cooperation with physicians, pharmacists, other care personnel, renowned scientists, organizations and associations, and with committed partner companies.

6th Edition of Drug Interactions available

1st Edition Selected Schedules in the Therapy of Childhood Cancers available

Recently published Highlights
Endoxan in Breast Cancer

Sales Folder Malignant Lymphomas
HOLOXAN, ENDOXAN
Essential components of effective chemotherapy regimens for malignant lymphomas.

Sales Folder Breast
ENDOXAN (Cyclophosphamide)
Essential and well-established cytotoxic component of effective chemotherapeutic regimens in the treatment of breast cancer.

Sales Folder Sarcomas
HOLOXAN, ENDOXAN
(Ifosfamide & Cyclophosphamide) Essential and well-established cytotoxic components of effective chemotherapeutic regimens for the treatment of adult and pediatric sarcomas.

16th Edition of Selected Schedules available

16th Edition of Selected Schedules Chinese available

 

Copyright © 2013 Baxter Oncology GmbH. All rights reserved.
Copyright and Legal Disclaimer